Overall Technical outlook

Price Summary

Alembic Pharmaceuticals Limited's stock began trading at 721.15 on 2026-06-03, soared to 728.0, dipped to 710.6, and finished the day 0.33% higher at 723.55, with 68595 shares exchanged.
Over the previous 52 weeks, the stock reached a high of 1039.1 and a low of 646.55.

Technicals

Support and Resistance: At 723.55, the price is held up by support at 698.3 and faces resistance at 724.4 for APLLTD. This suggests a trading range where 698.3 provides a base and 724.4 limits upward movement.
APLLTD supportResistance 385273
Support/Resistance for APLLTD


Aroon: The AROON is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market.
APLLTD aroon 385273
Aroon chart for Alembic Pharmaceuticals Limited


Bol. Bands: The BOLL BANDS is showing a neutral stance, not indicating a clear upward or downward trend for Alembic Pharmaceuticals Limited. This suggests a period of market balance, where neither side is showing dominance.
APLLTD bbands 385273
Bolinger Bands chart for Alembic Pharmaceuticals Limited


Parabolic SAR: The PSAR maintains its bearish stance, establishing a resistance level that could cap any attempts at upward movement. This persistent bearish outlook suggests that the market may continue to face downward pressure, with resistance preventing significant gains.
APLLTD psar 385273
Parabolic Stop and Reverse chart for Alembic Pharmaceuticals Limited


Stochastic: With the Stochastic K-line under the D-line and below 20, the market shows a mildly bearish trend. This positioning suggests that APLLTD may face some downside risk, though the bearish signal is not particularly strong. Traders should consider this as a cautious indicator.
APLLTD stoch 385273
Stochastic chart for Alembic Pharmaceuticals Limited


Tripple Moving Agerage: The Tripple MOVING AVG is showing a neutral stance, with no definitive indication of an upward or downward trend for APLLTD. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
APLLTD trippleSMA 385273
Tripple SMA chart for Alembic Pharmaceuticals Limited


When assessing a company's technical performance, such as stock price fluctuations and trading volume, it is crucial to first examine its fundamentals. These fundamentals include financial health, profitability, and growth potential. Additionally, understanding the industry's dynamics, including competitive pressures and market trends, is key to contextualizing the company's performance. By integrating these factors, a more comprehensive and meaningful analysis can be conducted, leading to more informed investment decisions.